Brandes Investment Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Brandes Investment Partners's GILD Position: Q1 2022 in Review
Brandes Investment Partners sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 65,436 shares — an estimated $4.75M sold.
Brandes Investment Partners first reported a position in GILD in Q1 2017 and held it in 20 quarters. The position peaked at $7.84M in Q2 2017. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- Brandes Investment Partners reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
- Brandes Investment Partners sold 65,436 Gilead Sciences shares in Q1 2022, an estimated $4.75M.
- Brandes Investment Partners first reported a position in Gilead Sciences in Q1 2017 and held it in 20 quarters.
- Brandes Investment Partners's Gilead Sciences position peaked at $7.84M in Q2 2017.
- 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on Brandes Investment Partners's 13F filing for Q1 2022, filed 10 May 2022.